{"transactions":[{"id":1177749,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81061,"kind":"person","name":"Smith Devin Whittemore","position":1,"cik":"0001747818","reported_name":"Smith Devin Whittemore","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-04T20:13:48.000Z","date":"2025-04-02","kind":"grant","planned":false,"acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of these options vest on April 2, 2026, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control."}],"balance_after":140000,"derivative":{"exercise_price":1.07,"expiration_date":"2035-04-02","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0000905148-25-001094","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000090514825001094/form4.xml","form_type":"4"}},{"id":1322974,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81061,"kind":"person","name":"Smith Devin Whittemore","position":1,"cik":"0001747818","reported_name":"Smith Devin Whittemore","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2024-12-23T23:52:18.000Z","date":"2024-12-23","kind":"purchase","planned":false,"acquired":true,"shares":12000,"price":0.81,"value":9720.0,"ownership":{"direct":true},"balance_after":16938,"source":{"system":"sec-edgar","filing":"0000905148-24-003408","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000090514824003408/form4.xml","form_type":"4"}},{"id":1572651,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81061,"kind":"person","name":"Smith Devin Whittemore","position":1,"cik":"0001747818","reported_name":"Smith Devin Whittemore","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-18T20:23:03.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of these options vest on March 15, 2025, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control."}],"balance_after":185000,"derivative":{"exercise_price":1.65,"expiration_date":"2034-03-15","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0000905148-24-000968","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000090514824000968/form4.xml","form_type":"4"}},{"id":1812153,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81061,"kind":"person","name":"Smith Devin Whittemore","position":1,"cik":"0001747818","reported_name":"Smith Devin Whittemore","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Warrants (Right to Buy)","published_at":"2023-08-10T00:38:33.000Z","date":"2023-08-09","kind":"grant","planned":false,"acquired":true,"shares":4938,"price":0.125,"value":617.25,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These Warrants expire at 5:00 p.m. Eastern time on the earlier of (i) February 9, 2027, and (ii) one day prior to the closing of an Acquisition of the Issuer, as defined in the Form of Warrant, attached as Exhibit 4.1 to the Issuer's Current Report on Form 8-K, filed with the Securities and Exchange Commission on August 7, 2023."}],"balance_after":4938,"derivative":{"exercise_price":2.47,"exercise_date":"2023-08-09","underlying":"Common Stock","underlying_shares":4938},"source":{"system":"sec-edgar","filing":"0001140361-23-038877","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000114036123038877/form4.xml","form_type":"4"}},{"id":1812152,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81061,"kind":"person","name":"Smith Devin Whittemore","position":1,"cik":"0001747818","reported_name":"Smith Devin Whittemore","relationship":{"officer":true,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2023-08-10T00:38:33.000Z","date":"2023-08-09","kind":"grant","planned":false,"acquired":true,"shares":4938,"price":1.9,"value":9382.2,"ownership":{"direct":true},"balance_after":4938,"source":{"system":"sec-edgar","filing":"0001140361-23-038877","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000114036123038877/form4.xml","form_type":"4"}},{"id":2054891,"issuer":{"id":8764,"kind":"organization","name":"IO Biotech, Inc."},"owners":[{"id":81061,"kind":"person","name":"Smith Devin Whittemore","position":1,"cik":"0001747818","reported_name":"Smith Devin Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-13T21:49:09.000Z","date":"2023-01-12","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-fourth of these options vest on January 12, 2024, and 1/36th of the remaining options vest each month thereafter, subject to the reporting person's continued service through the applicable vesting date, and subject to 25% acceleration upon termination of service by the Issuer without cause and 100% acceleration upon termination of service by the Issuer without cause if such termination occurs within 24 months of a change of control."}],"balance_after":150000,"derivative":{"exercise_price":2.6,"expiration_date":"2033-01-12","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001567619-23-000919","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865494/000156761923000919/doc1.xml","form_type":"4"}},{"id":2094579,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":81061,"kind":"person","name":"Smith Devin Whittemore","position":1,"cik":"0001747818","reported_name":"Smith Devin Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-12-06T16:51:28.000Z","date":"2022-12-02","kind":"sale","acquired":false,"shares":3116,"price":1.691,"value":5269.156,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of shares of restricted stock granted to the Reporting Person. This sale is mandated by the Issuer, Yumanity Therapeutics, Inc., to satisfy tax withholding obligations by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.69 to $1.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":13961,"source":{"system":"sec-edgar","filing":"0000899243-22-037785","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1747818/000089924322037785/doc4.xml","form_type":"4"}},{"id":2242472,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":81061,"kind":"person","name":"Smith Devin Whittemore","position":1,"cik":"0001747818","reported_name":"Smith Devin Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2022-06-06T21:46:05.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":2923,"price":1.1946,"value":3491.8158,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of shares of restricted stock granted to the Reporting Person. This sale is mandated by the Issuer, Yumanity Therapeutics, Inc., to satisfy tax withholding obligations by a \"sell to cover\" transaction and does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.14 to $1.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."}],"balance_after":17077,"source":{"system":"sec-edgar","filing":"0000899243-22-021285","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1747818/000089924322021285/doc4.xml","form_type":"4"}},{"id":2486087,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":81061,"kind":"person","name":"Smith Devin Whittemore","position":1,"cik":"0001747818","reported_name":"Smith Devin Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Common Stock","published_at":"2021-12-03T16:15:15.000Z","date":"2021-12-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award granted under the Yumanity Therapeutics, Inc. Amended and Restated 2018 Stock Option and Grant Plan. Fifty percent of the shares subject to the award will vest six months after the grant date and fifty percent will vest twelve months after the grant date, provided that the award recipient continues to have a service relationship with the Company at such time."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000899243-21-046761","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1747818/000089924321046761/doc4.xml","form_type":"4"}},{"id":2666441,"issuer":{"id":77778,"kind":"organization","name":"KINETA, INC./DE","symbol":"KANT"},"owners":[{"id":81061,"kind":"person","name":"Smith Devin Whittemore","position":1,"cik":"0001747818","reported_name":"Smith Devin Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-16T17:14:49.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":58400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on June 14, 2022. The remaining 75% vest in equal monthly installments over the subsequent three years."}],"balance_after":58400,"derivative":{"exercise_price":16.2,"expiration_date":"2031-06-12","underlying":"Common Stock","underlying_shares":58400},"source":{"system":"sec-edgar","filing":"0000899243-21-024171","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1747818/000089924321024171/doc4.xml","form_type":"4"}},{"id":3007302,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":81061,"kind":"person","name":"Smith Devin Whittemore","position":1,"cik":"0001747818","reported_name":"Smith Devin Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-10-14T17:23:30.000Z","date":"2020-10-13","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of this option vests on December 31, 2021 and the balance vests on December 31, 2022."}],"balance_after":85000,"derivative":{"exercise_price":3.5,"expiration_date":"2030-10-12","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001209191-20-054807","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1747818/000120919120054807/doc4.xml","form_type":"4"}},{"id":3056053,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":81061,"kind":"person","name":"Smith Devin Whittemore","position":1,"cik":"0001747818","reported_name":"Smith Devin Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-08-17T16:32:52.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":153531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted by Issuer's Board of Directors on December 31, 2019 contingent upon stockholder approval of an amendment and restatement of Issuer's equity incentive plan to increase the number of shares available for issuance under such plan, which was received on June 19, 2020. This option vests 25% on December 31, 2020 and then in quarterly installments over 3 years thereafter."}],"balance_after":153531,"derivative":{"exercise_price":7.11,"expiration_date":"2029-12-31","underlying":"Common Stock","underlying_shares":153531},"source":{"system":"sec-edgar","filing":"0001209191-20-046957","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1747818/000120919120046957/doc4.xml","form_type":"4"}},{"id":3323538,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":81061,"kind":"person","name":"Smith Devin Whittemore","position":1,"cik":"0001747818","reported_name":"Smith Devin Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-03T16:53:40.000Z","date":"2019-12-31","kind":"grant","acquired":true,"shares":41469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests 25% on December 31, 2019 and then in quarterly installments over 3 years thereafter."}],"balance_after":41469,"derivative":{"exercise_price":7.11,"expiration_date":"2029-12-30","underlying":"Common Stock","underlying_shares":41469},"source":{"system":"sec-edgar","filing":"0001209191-20-001129","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1747818/000120919120001129/doc4.xml","form_type":"4"}},{"id":3732306,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":81061,"kind":"person","name":"Smith Devin Whittemore","position":1,"cik":"0001747818","reported_name":"Smith Devin Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-12-13T16:45:36.000Z","date":"2018-12-11","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests 25% on December 11, 2019 and then in quarterly installments over 3 years thereafter."}],"balance_after":120000,"derivative":{"exercise_price":7.96,"expiration_date":"2028-12-10","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001209191-18-062467","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1747818/000120919118062467/doc4.xml","form_type":"4"}},{"id":3855159,"issuer":{"id":6245,"kind":"organization","name":"Minerva Neurosciences, Inc."},"owners":[{"id":81061,"kind":"person","name":"Smith Devin Whittemore","position":1,"cik":"0001747818","reported_name":"Smith Devin Whittemore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP and General Counsel"}}],"security":"Employee Stock Option (Righ to Buy)","published_at":"2018-08-02T16:57:49.000Z","date":"2018-08-01","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 25% of the shares on July 23, 2019 and then in quarterly installments over 3 years thereafter."}],"balance_after":200000,"derivative":{"exercise_price":7.95,"expiration_date":"2028-08-01","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-18-045007","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1747818/000120919118045007/doc4.xml","form_type":"4"}}]}